LKFT — LAKEFRONT BIOTHERAPEUTICS NV
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 79 家机构在其最新 13F 申报中持有 LKFT(LAKEFRONT BIOTHERAPEUTICS NV),合计申报市值 $959.93M,对应 32.04M 股。按股数计算较上季度增持 5.4%(+1.62M 股),申报市值环比上升 5.2%。持仓集中度较高:前五大持有人占申报市值的 86.3%,前十大的集中度为 94.9%。
与上一季度相比,11 家新建仓位、27 家加仓、26 家减仓、22 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
LAKEFRONT BIOTHERAPEUTICS NV(LKFT)的主要机构持有人包括 GILEAD SCIENCES, INC.、TANG CAPITAL MANAGEMENT LLC、Madison Avenue Partners, LP,按 13F 申报市值在本页 186 家持有人中排名居前。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 66 | 21.12M | $632.19M | +3.1% |
| Q2 2026 | 79 | 32.04M | $959.93M | +5.3% |
| Q1 2026 | 89 | 31.10M | $933.05M | -0.5% |
| Q4 2025 | 89 | 31.23M | $1.03B | -0.1% |
| Q3 2025 | 93 | 31.40M | $1.09B | -0.9% |
| Q2 2025 | 87 | 31.99M | $895.50M | +5.8% |
| Q1 2025 | 84 | 31.30M | $785.91M | +4.3% |
| Q4 2024 | 82 | 31.13M | $858.24M | +6.5% |
表内 8 个季度中,机构持股合计减少 32%(Q4 2024 → Q3 2026);单季变动最大的是 Q4 2024(+6.5%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 16.71M | $501.28M | 34.24% | 持有 | |
| 2.00M | $59.25M | 11.49% | 减持 | |
| 647.52K | $19.20M | 0.01% | 增持 | |
| 424.70K | $12.59M | 0.02% | 增持 | |
| 394.01K | $11.68M | 0.00% | 增持 | |
| 311.63K | $9.24M | 0.00% | 新进 | |
| 88.25K | $2.62M | 0.01% | 增持 | |
| 78.46K | $2.33M | 0.00% | 增持 | |
| 65.90K | $1.95M | 0.00% | 新进 | |
| 50.79K | $1.50M | 0.01% | 增持 | |
| 41.37K | $1.23M | 0.00% | 增持 | |
| 40.82K | $1.21M | 0.00% | 增持 | |
| 40.80K | $1.21M | 0.35% | 持有 | |
| 33.82K | $1.00M | 0.26% | 增持 | |
| 33.38K | $989.84K | 0.01% | 增持 | |
| 29.91K | $886.89K | 0.03% | 新进 | |
| 26.37K | $781.96K | 0.01% | 新进 | |
| 20.00K | $593.00K | 0.09% | 减持 | |
| 14.00K | $413.28K | 0.00% | 持有 | |
| 13.14K | $389.69K | 0.23% | 新进 | |
| 10.07K | $298.69K | 0.00% | 增持 | |
| 9.39K | $278.53K | 0.00% | 减持 | |
| 7.78K | $230.68K | 0.00% | 新进 | |
| 7.30K | $216.53K | 0.00% | 持有 | |
| 7.03K | $208.44K | 0.00% | 新进 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 16.71M | $500.16M | 30.34% | 持有 | |
| 3.79M | $113.50M | 5.16% | 持有 | |
| 3.45M | $103.37M | 4.45% | 增持 | |
| 2.04M | $61.26M | 10.56% | 增持 | |
| 1.67M | $49.98M | 2.56% | 持有 | |
| 1.27M | $38.14M | 0.01% | 减持 | |
| 482.75K | $14.47M | 0.37% | 持有 | |
| 407.80K | $12.23M | 0.02% | 增持 | |
| 338.15K | $10.14M | 0.00% | 增持 | |
| 269.81K | $8.09M | 0.03% | 减持 | |
| 197.84K | $5.93M | 0.01% | 减持 | |
| 181.09K | $5.43M | 0.01% | 增持 | |
| 168.15K | $5.04M | 0.00% | 减持 | |
| 151.89K | $4.55M | 0.00% | 增持 | |
| 130.18K | $3.90M | 0.74% | 持有 | |
| 88.34K | $2.65M | 0.00% | 增持 | |
| 81.75K | $2.45M | 0.00% | 增持 | |
| 76.88K | $2.30M | 0.00% | 减持 | |
| 65.52K | $1.96M | 0.01% | 增持 | |
| 56.58K | $1.70M | 0.00% | 增持 | |
| 40.80K | $1.22M | 0.00% | 增持 | |
| 40.80K | $1.22M | 0.34% | 增持 | |
| 37.68K | $1.13M | 0.00% | 增持 | |
| 32.60K | $977.26K | 0.01% | 新进 | |
| 32.40K | $971.32K | 0.00% | 新进 |
Q1 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 16.71M | $501.22M | 23.67% | 持有 | |
| 3.79M | $113.58M | 5.77% | 减持 | |
| 2.47M | $73.96M | 3.22% | 增持 | |
| 1.67M | $50.01M | 2.36% | 持有 | |
| 1.55M | $46.50M | 7.62% | 增持 | |
| 1.42M | $42.74M | 0.01% | 减持 | |
| 482.75K | $14.48M | 0.45% | 持有 | |
| 426.41K | $12.79M | 0.18% | 减持 | |
| 332.12K | $9.96M | 0.04% | 减持 | |
| 315.40K | $9.46M | 0.01% | 增持 | |
| 312.11K | $9.36M | 0.00% | 减持 | |
| 215.72K | $6.47M | 0.01% | 减持 | |
| 175.29K | $5.26M | 0.00% | 减持 | |
| 130.18K | $3.91M | 0.90% | 持有 | |
| 107.91K | $3.24M | 0.00% | 减持 | |
| 95.59K | $2.87M | 0.08% | 新进 | |
| 80.21K | $2.41M | 0.01% | 增持 | |
| 77.50K | $2.33M | 0.02% | 减持 | |
| 66.54K | $2.00M | 0.05% | 增持 | |
| 53.66K | $1.61M | 0.01% | 持有 | |
| 45.37K | $1.36M | 0.00% | 增持 | |
| 45.17K | $1.35M | 0.01% | 新进 | |
| 38.79K | $1.16M | 0.00% | 增持 | |
| 38.10K | $1.14M | 0.39% | 增持 | |
| 32.61K | $978.21K | 0.01% | 减持 |
Q4 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 16.71M | $550.62M | 28.45% | 持有 | |
| 3.92M | $128.22M | 6.33% | 减持 | |
| 2.21M | $72.37M | 3.11% | 增持 | |
| 1.67M | $54.51M | 2.57% | 持有 | |
| 1.45M | $47.46M | 0.01% | 增持 | |
| 1.07M | $35.12M | 7.26% | 减持 | |
| 486.21K | $15.90M | 0.06% | 增持 | |
| 482.75K | $15.79M | 0.55% | 持有 | |
| 448.10K | $14.65M | 0.20% | 减持 | |
| 349.44K | $11.43M | 0.01% | 增持 | |
| 339.35K | $11.10M | 0.02% | 增持 | |
| 314.27K | $10.28M | 0.00% | 增持 | |
| 310.60K | $10.16M | 0.02% | 减持 | |
| 275.00K | $8.99M | 0.02% | 增持 | |
| 170.00K | $5.56M | 0.04% | 减持 | |
| 130.18K | $4.26M | 1.00% | 持有 | |
| 90.00K | $2.94M | 0.00% | 减持 | |
| 68.28K | $2.23M | 0.00% | 增持 | |
| 56.97K | $1.86M | 0.00% | 增持 | |
| 53.79K | $1.76M | 0.01% | 增持 | |
| 47.58K | $1.56M | 0.01% | 增持 | |
| 43.86K | $1.43M | 0.01% | 减持 | |
| 39.00K | $1.28M | 0.21% | 新进 | |
| 32.98K | $1.08M | 0.01% | 持有 | |
| 32.52K | $1.06M | 0.19% | 减持 |
Q3 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 16.71M | $578.75M | 32.31% | 持有 | |
| 4.15M | $143.80M | 5.54% | 增持 | |
| 2.20M | $76.06M | 4.54% | 增持 | |
| 1.67M | $57.75M | 2.77% | 增持 | |
| 1.42M | $49.08M | 0.01% | 增持 | |
| 1.15M | $39.84M | 9.29% | 减持 | |
| 487.20K | $16.88M | 0.23% | 减持 | |
| 482.75K | $16.72M | 0.66% | 持有 | |
| 443.87K | $15.38M | 0.06% | 增持 | |
| 356.20K | $12.34M | 0.02% | 减持 | |
| 245.00K | $8.49M | 0.08% | 减持 | |
| 239.84K | $8.31M | 0.00% | 增持 | |
| 201.17K | $6.97M | 0.01% | 增持 | |
| 153.00K | $5.30M | 0.00% | 减持 | |
| 152.90K | $5.30M | 0.01% | 减持 | |
| 130.18K | $4.51M | 1.13% | 持有 | |
| 90.00K | $3.12M | 0.00% | 减持 | |
| 87.57K | $3.03M | 0.01% | 增持 | |
| 66.14K | $2.29M | 0.00% | 增持 | |
| 64.06K | $2.22M | 0.00% | 减持 | |
| 54.01K | $1.87M | 0.00% | 减持 | |
| 51.30K | $1.78M | 0.02% | 增持 | |
| 50.50K | $1.75M | 0.00% | 减持 | |
| 47.54K | $1.65M | 0.26% | 新进 | |
| 39.00K | $1.35M | 0.00% | 减持 |
Q2 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 16.71M | $467.64M | 36.53% | 持有 | |
| 3.99M | $111.68M | 5.64% | 增持 | |
| 1.88M | $52.54M | 3.51% | 新进 | |
| 1.77M | $49.64M | 12.11% | 增持 | |
| 1.55M | $43.30M | 0.00% | 减持 | |
| 1.04M | $29.02M | 1.78% | 增持 | |
| 501.08K | $14.03M | 0.20% | 减持 | |
| 482.75K | $13.51M | 0.58% | 持有 | |
| 464.70K | $13.01M | 0.02% | 增持 | |
| 341.50K | $9.56M | 0.05% | 新进 | |
| 285.30K | $7.99M | 0.23% | 增持 | |
| 283.40K | $7.93M | 0.08% | 减持 | |
| 283.40K | $7.93M | 0.15% | 新进 | |
| 238.52K | $6.68M | 0.00% | 增持 | |
| 226.06K | $6.33M | 0.00% | 减持 | |
| 190.71K | $5.34M | 0.01% | 增持 | |
| 153.19K | $4.29M | 0.01% | 增持 | |
| 143.31K | $4.01M | 0.00% | 减持 | |
| 130.18K | $3.64M | 1.04% | 持有 | |
| 120.00K | $3.36M | 0.00% | 持有 | |
| 85.40K | $2.39M | 0.01% | 新进 | |
| 80.86K | $2.26M | 0.00% | 增持 | |
| 79.14K | $2.21M | 0.06% | 增持 | |
| 78.93K | $2.21M | 0.01% | 增持 | |
| 75.00K | $2.10M | 0.11% | 增持 |
新建仓(Q2 2026)
- Schonfeld Strategic Advisors LLC 32.60K 股 · $977.26K
- Marshall Wace 32.40K 股 · $971.32K
- GEODE CAPITAL MANAGEMENT, LLC 10.15K 股 · $304.30K
- Mirae Asset Global Investments Co., Ltd. 672 股 · $20.15K
- Blue Trust, Inc. 249 股 · $7.46K
- EVENTIDE ASSET MANAGEMENT, LLC 94 股 · $2.79K
- Silver Grove Financial Group, Inc. 65 股 · $1.95K
- Integrated Wealth Concepts LLC 13 股 · $390
- First Command Advisory Services, Inc. 12 股 · $360
- BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. 3 股 · $90
- BFC Planning, Inc. 3 股 · $90
完全清仓(较上季)
- SEGALL BRYANT & HAMILL, LLC 卖出 426.41K 股 · $12.79M
- OLD MISSION CAPITAL LLC 卖出 95.59K 股 · $2.87M
- Man Group plc 卖出 80.21K 股 · $2.41M
- Hudson Bay Capital Management LP 卖出 77.50K 股 · $2.33M
- Optiver Holding B.V. 卖出 26.54K 股 · $796.05K
- XTX Topco Ltd 卖出 25.40K 股 · $762.12K
- MOODY NATIONAL BANK TRUST DIVISION 卖出 20.85K 股 · $625.47K
- JANE STREET GROUP, LLC 卖出 13.61K 股 · $408.21K
- VOLORIDGE INVESTMENT MANAGEMENT, LLC 卖出 13.51K 股 · $405.15K
- Squarepoint Ops LLC 卖出 12.95K 股 · $388.56K
- ABC ARBITRAGE SA 卖出 12.74K 股 · $382.32K
- COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 卖出 8.27K 股 · $248.19K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | 16.71M | 16.71M | 16.71M | 16.71M | 16.71M | 16.71M | 16.71M | 16.71M | — | — | — | — | — | — | — | — | — | — | — | — |
| Prosight Management, LP | 2.00M | 2.04M | 1.55M | 1.07M | 1.15M | 1.77M | 1.31M | 1.02M | 1.03M | 1.35M | 931.51K | 827.29K | 730.21K | — | — | — | — | — | — | — |
| UBS Group AG | 647.52K | 168.15K | 175.29K | 349.44K | 153.00K | 238.52K | 109.01K | 75.58K | 982 | 1.06K | 1.38K | 1.96K | 679 | — | — | — | — | — | — | — |
| Renaissance Technologies | 424.70K | 407.80K | 315.40K | 310.60K | 356.20K | 464.70K | 330.80K | 296.10K | 291.68K | 270.80K | 266.50K | 263.20K | 281.80K | 307.90K | 358.40K | 336.38K | 298.60K | 248.30K | 84.50K | 56.60K |
| BlackRock Inc | 394.01K | 338.15K | 312.11K | 314.27K | 239.84K | 226.06K | 253.95K | 424.66K | 504.27K | — | — | — | — | — | — | — | — | — | — | — |
| Arrowstreet Capital | 311.63K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 31.99K | — |
| ALPS ADVISORS INC | 88.25K | 65.52K | 53.66K | 53.79K | 31.91K | 35.38K | 48.29K | 53.45K | 49.90K | 51.45K | 46.71K | 45.72K | 48.31K | — | — | — | — | — | — | — |
| Marshall Wace | 78.46K | 32.40K | — | 11.20K | 38.46K | — | — | — | — | 12.71K | — | — | — | — | — | — | — | — | — | — |
| Qube Research & Technologies Ltd | 65.90K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| HRT FINANCIAL LP | 50.79K | 17.33K | 45.17K | — | 8.70K | — | — | — | 16.24K | — | — | — | — | — | — | — | — | — | — | — |
| AMERICAN CENTURY COMPANIES INC | 41.37K | 40.80K | 38.79K | 26.73K | 27.60K | 28.10K | 27.84K | 25.85K | 24.42K | 23.71K | 23.71K | 23.47K | 22.13K | — | — | — | — | — | — | — |
| Morgan Stanley | 40.82K | 37.68K | 26.62K | 68.28K | 64.06K | 66.16K | 25.41K | 144.14K | 84.36K | 113.73K | 23.66K | 111.33K | 23.35K | — | — | — | — | — | — | — |
| BAROMETER CAPITAL MANAGEMENT INC. | 40.80K | 40.80K | 38.10K | 37.10K | 27.62K | 16.92K | 13.52K | 9.42K | 10.72K | 9.42K | 7.72K | 3.00K | — | — | — | — | — | — | — | — |
| denkapparat Operations GmbH | 33.82K | 21.32K | 10.64K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Crossmark Global Holdings, Inc. | 33.38K | 10.54K | 32.61K | 32.98K | 32.90K | 47.44K | 49.33K | 49.16K | 37.39K | — | — | — | — | — | — | — | — | — | — | — |
| Entropy Technologies, LP | 29.91K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Magnetar Financial LLC | 26.37K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Monaco Asset Management SAM | 20.00K | 25.60K | 27.52K | 32.52K | 33.54K | 36.04K | 36.04K | 15.00K | 21.00K | 21.00K | 16.74K | 6.74K | 8.46K | — | — | — | — | — | — | — |
| Erste Asset Management GmbH | 14.00K | 14.00K | 14.00K | 14.00K | 14.00K | 14.00K | 14.00K | 14.00K | 14.00K | 14.00K | 14.00K | 14.00K | — | — | — | — | — | — | — | — |
| MQS Management LLC | 13.14K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold LKFT?
As of 2026-Q2, 79 institutional funds reported holding LKFT (LAKEFRONT BIOTHERAPEUTICS NV) in SEC 13F filings, with a combined reported value of $959.93M.
How many shares of LKFT do institutions own?
13F filers reported 32.04M shares of LKFT, worth $959.93M in aggregate at the end of 2026-Q2.
Is institutional ownership of LKFT rising or falling?
Share counts moved +5.4% versus the prior quarter — accumulation.
Who are the top institutional holders of LKFT?
The largest 13F holders are GILEAD SCIENCES, INC., TANG CAPITAL MANAGEMENT LLC, Madison Avenue Partners, LP, Prosight Management, LP, EcoR1 Capital, LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of LAKEFRONT BIOTHERAPEUTICS NV?
The major shareholders of LAKEFRONT BIOTHERAPEUTICS NV (LKFT) by reported 13F value are GILEAD SCIENCES, INC., TANG CAPITAL MANAGEMENT LLC, Madison Avenue Partners, LP, Prosight Management, LP, EcoR1 Capital, LLC, among 186 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.